145 related articles for article (PubMed ID: 9817285)
21. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
22. Fine structure analysis of the WT1 gene in sporadic Wilms tumors.
Varanasi R; Bardeesy N; Ghahremani M; Petruzzi MJ; Nowak N; Adam MA; Grundy P; Shows TB; Pelletier J
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3554-8. PubMed ID: 8170946
[TBL] [Abstract][Full Text] [Related]
23. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
24. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
25. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
Eccles MR; Yun K; Reeve AE; Fidler AE
Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.
Lehnhardt A; Karnatz C; Ahlenstiel-Grunow T; Benz K; Benz MR; Budde K; Büscher AK; Fehr T; Feldkötter M; Graf N; Höcker B; Jungraithmayr T; Klaus G; Koehler B; Konrad M; Kranz B; Montoya CR; Müller D; Neuhaus TJ; Oh J; Pape L; Pohl M; Royer-Pokora B; Querfeld U; Schneppenheim R; Staude H; Spartà G; Timmermann K; Wilkening F; Wygoda S; Bergmann C; Kemper MJ
Clin J Am Soc Nephrol; 2015 May; 10(5):825-31. PubMed ID: 25818337
[TBL] [Abstract][Full Text] [Related]
27. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
[TBL] [Abstract][Full Text] [Related]
28. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
29. The Wilms' tumor suppressor WT1: approaches to gene function.
Menke A; McInnes L; Hastie ND; Schedl A
Kidney Int; 1998 Jun; 53(6):1512-8. PubMed ID: 9607183
[TBL] [Abstract][Full Text] [Related]
30. Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant.
Falcone MP; Pritchard-Jones K; Brok J; Mifsud W; Williams RD; Nakata K; Tugnait S; Al-Saadi R; Side L; Anderson J; Duncan C; Marks SD; Bockenhauer D; Chowdhury T
Pediatr Nephrol; 2022 Apr; 37(4):821-832. PubMed ID: 34608521
[TBL] [Abstract][Full Text] [Related]
31. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
32. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
[TBL] [Abstract][Full Text] [Related]
33. A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.
Terenziani M; Sardella M; Gamba B; Testi MA; Spreafico F; Ardissino G; Fedeli F; Fossati-Bellani F; Radice P; Perotti D
Pediatr Nephrol; 2009 Jul; 24(7):1413-7. PubMed ID: 19048299
[TBL] [Abstract][Full Text] [Related]
34. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
35. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor.
Nakadate H; Tsuchiya T; Maseki N; Hatae Y; Tsunematsu Y; Horikoshi Y; Ishida Y; Kikuta A; Eguchi H; Endo M; Miyake M; Sakurai M; Kaneko Y
Genes Chromosomes Cancer; 1999 May; 25(1):26-32. PubMed ID: 10221336
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122
[TBL] [Abstract][Full Text] [Related]
37. Two molecular subgroups of Wilms' tumors with or without WT1 mutations.
Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B
Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362
[TBL] [Abstract][Full Text] [Related]
38. WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis.
Denamur E; Bocquet N; Baudouin V; Da Silva F; Veitia R; Peuchmaur M; Elion J; Gubler MC; Fellous M; Niaudet P; Loirat C
Kidney Int; 2000 May; 57(5):1868-72. PubMed ID: 10792605
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
40. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
